title: Synthesis and binding potencies of cyclic hexapeptide analogs of somatostatin incorporating acidic and basic peptoid residues.
abstract: The synthesis, binding affinity, and structure-activity relationships of compounds related to the cyclic hexapeptide, c[Pro6-Phe7-D-Trp8-Lys9-Thr10-Phe11], L-363,301 (the numbering in the sequence refers to the position of the residue in native somatostatin) is reported. The Pro residue in this compound is replaced with the peptoid residues Nasp [N-(2-carboxyethyl) glycine], Ndab [N-(2-aminoethyl) glycine] and Nlys [N-(4-aminobutyl) glycine]. This series of compounds enables us to draw conclusions about the influence of positively or negatively charged residues in the bridging region on the binding affinity towards the isolated human somatostatin receptors. A loss of binding to the recombinant human somatostatin (hsst) receptors in the Nasp analog compared with L-363,301 and compared with the Ndab and Nlys analogs clearly demonstrates that the presence of an acidic residue in the bridging region is unfavorable for binding to the hsst receptors. Comparison between the Ndab analog and the Nlys analog suggests that the presence of a basic residue in the bridging region might be advantageous for binding to the hsst5 receptor provided that the residue bearing the basic group extends far enough to allow for interaction with the receptor, while the length of the basic peptoid residue does not influence binding to the hsst2 receptor. These results are useful for the design of hsst5 selective somatostatin analogs.
authors: Department of Chemistry and Biochemistry, University of California at San Diego, La Jolla 92093-0343, USA.
authors: T A
authors: TA
authors: Tran
authors: R H
authors: RH
authors: Mattern
authors: B A
authors: BA
authors: Morgan
authors: J E
authors: JE
authors: Taylor
authors: M
authors: M
authors: Goodman
mesh_terms: D002851:Chromatography, High Pressure Liquid; D005998:Glycine / Q000031:analogs & derivatives / Q000737:chemistry; D006801:Humans; D006860:Hydrogen Bonding; D010446:Peptide Fragments / Q000138:chemical synthesis* / Q000378:metabolism*; D010456:Peptides, Cyclic / Q000138:chemical synthesis* / Q000378:metabolism; D034444:Peptoids; D017481:Receptors, Somatostatin / Q000378:metabolism*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000378:metabolism; D013329:Structure-Activity Relationship
chemical_list: D010446:Peptide Fragments; D010456:Peptides, Cyclic; D034444:Peptoids; D017481:Receptors, Somatostatin; C040704:cyclo(Pro-Phe-Trp-Lys-Thr-Phe); C028791:N-(2-aminoethyl)glycine; D013004:Somatostatin; D005998:Glycine